Related Experiment Video
Updated: Jun 7, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
IL-1β promotes glutamate excitotoxicity: indications for the link between inflammatory and synaptic vesicle cycle in
Na Zhang1,2,3, Yongdong Song1,2,3, Hanyue Wang1,3
1Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong, China.
Abstract:
Ménière's disease (MD) is a complex inner ear disorder characterized by a range of symptoms, with its pathogenesis linked to immune-related mechanisms. Our previous research demonstrated that IL-1β maturation and release can trigger cell pyroptosis, exacerbating the severity of the endolymphatic hydrops in a mouse model; however, the specific mechanism through which IL-1β influences MD symptoms remains unclear. This study conducted on patients with MD examined changes in protein signatures in the vestibular end organs (VO) and endolymphatic sac (ES) using mass spectrometry. Gene ontology and protein pathway analyses showed that differentially expressed proteins in the ES are closely related to adhesion, whereas those in the VO are related to synapse processes. Additionally, the study found elevated expression of Glutaminase (GLS) in the VO of MD patients compared to controls. Further investigations revealed that IL-1β increased glutamate levels by upregulating GLS expression in HEI-OC1 cells. Treatment with a GLS inhibitor or an IL-1β receptor antagonist alleviated auditory-vestibular dysfunction and reduced glutamate levels in mice with endolymphatic hydrops. These findings collectively suggest that imbalanced neurotransmitter release and immune responses contribute to the pathology of MD, potentially explaining the hearing loss and vertigo associated with the disease and offering new avenues for therapeutic interventions.
Insights
Interleukin-1 beta (IL-1β) elevates glutamate in Ménière
Area of Science:
- Inner ear disorders
- Neuroimmunology
- Otolaryngology
Background:
- Ménière's disease (MD) pathogenesis involves immune mechanisms.
- Previous studies linked IL-1β to pyroptosis and endolymphatic hydrops severity.
- The precise role of IL-1β in MD symptoms was previously unclear.
Purpose of the Study:
- To investigate the molecular mechanisms linking IL-1β to Ménière's disease.
- To identify protein changes in the vestibular end organs (VO) and endolymphatic sac (ES) of MD patients.
- To explore the role of glutamate metabolism in MD.
Main Methods:
- Mass spectrometry analysis of VO and ES protein signatures in MD patients.
- Gene ontology and protein pathway analysis.
- In vitro studies using HEI-OC1 cells to assess IL-1β effects on Glutaminase (GLS).
- In vivo studies using a mouse model of endolymphatic hydrops.
Main Results:
- Differentially expressed proteins in ES were linked to adhesion; VO proteins were linked to synapse processes.
- Elevated Glutaminase (GLS) expression was observed in the VO of MD patients.
- IL-1β upregulated GLS, increasing glutamate levels in HEI-OC1 cells.
- GLS inhibition or IL-1β receptor antagonism ameliorated auditory-vestibular dysfunction and reduced glutamate in mice.
Conclusions:
- Imbalanced neurotransmitter release and immune responses are implicated in MD pathology.
- Elevated glutamate, mediated by IL-1β and GLS, contributes to MD symptoms like hearing loss and vertigo.
- Targeting glutamate pathways and IL-1β signaling offers potential therapeutic strategies for MD.
More Related Videos
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
16:13Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...